ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 195 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $87,000 | -92.8% | 1,536 | -94.4% | 0.00% | -90.5% |
| Q2 2021 | $1,212,000 | +46.7% | 27,536 | +64.4% | 0.02% | +50.0% |
| Q1 2021 | $826,000 | +184.8% | 16,746 | +142.7% | 0.01% | +180.0% |
| Q4 2020 | $290,000 | -8.2% | 6,900 | 0.0% | 0.01% | -28.6% |
| Q3 2020 | $316,000 | -8.7% | 6,900 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $346,000 | -2.5% | 6,900 | 0.0% | 0.01% | -20.0% |
| Q1 2020 | $355,000 | -16.7% | 6,900 | 0.0% | 0.01% | +11.1% |
| Q4 2019 | $426,000 | -19.5% | 6,900 | -21.6% | 0.01% | -10.0% |
| Q3 2019 | $529,000 | +677.9% | 8,800 | +1000.0% | 0.01% | +900.0% |
| Q2 2019 | $68,000 | -10.5% | 800 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $76,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,055,719 | $35,367,000 | 12.68% |
| GREAT POINT PARTNERS LLC | 828,253 | $27,746,000 | 5.70% |
| McClain Value Management LLC | 116,153 | $3,891,000 | 4.80% |
| Stonepine Capital Management, LLC | 231,913 | $7,769,000 | 4.63% |
| ARMISTICE CAPITAL, LLC | 228,000 | $7,638,000 | 1.81% |
| Opaleye Management Inc. | 90,000 | $3,015,000 | 1.78% |
| Matarin Capital Management, LLC | 257,268 | $8,618,478,000 | 0.97% |
| HAYS ADVISORY LLC | 116,939 | $3,917,000 | 0.87% |
| Granahan Investment Management | 496,025 | $16,617,000 | 0.57% |
| AlphaMark Advisors, LLC | 33,000 | $1,106,000 | 0.57% |